Buscar
19/08/2024
'Gout was like the boss'. A qualitative study exploring the impact of gout on employment
Diaz-Torne, C, Pou, MA, Horne, A, Gasteiger, C, Dalbeth, N. 'Gout was like the boss'. A qualitative study exploring the impact of gout on employment. RMD Open. 2024; 10(3)DOI:10.1136/rmdopen-2024-004443. PMID:39160089. IF:4.700(Q1/1D).
01/04/2024
Application of the 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease in a seronegative rheumatoid arthritis cohort
Codes-Méndez, H, Sainz, L, Park, HS, Corominas, H, Diaz-Torne, C. Application of the 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease in a seronegative rheumatoid arthritis cohort. RMD Open. 2024; 10(2)DOI:10.1136/rmdopen-2024-004173. PMID:38626930. IF:4.700(Q1/1D).
01/08/2024
Diagnosed and undiagnosed cough-related stress urinary incontinence in women with refractory or unexplained chronic cough: Its impact on general health status and quality of life
Arismendi, E, Puente-Maestu, L, Domingo, C, Dávila, I, Quirce, S, González-Barcala, FJ, Crespo-Lessmann, A, Sánchez-Jareño, M, Rivas-Pardinas, C, Cea-Calvo, L. Diagnosed and undiagnosed cough-related stress urinary incontinence in women with refractory or unexplained chronic cough: Its impact on general health status and quality of life. Chronic Respiratory Disease. 2024; 21DOI:10.1177/14799731241273751. PMID:39222070. IF:2.300(Q2/5D).
01/05/2026
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial
Behrens, GMN, Assoumou, L, Liegeon, G, Antinori, A, Micán, R, Genderini, FG, Post, FA, Rockstroh, JK, Hamzah, L, Domingo, P, Curran, A, Laguno, M, Fletcher, C, Moody, J, Pozniak, A. Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial. LANCET INFECTIOUS DISEASES. 2026; 26(5)DOI:10.1016/S1473-3099(25)00681-4. PMID:41344354. IF:31.000(Q1/1D).